top of page

11/10/23 Public Health Education Topic: RSV

Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization. Vaccines are available to protect older adults from severe RSV. Preventive options are available to protect infants and young children from severe RSV.

To learn about Symptoms & Care, Prevention and the Transmission of RSV, visit:

RSV (Respiratory Syncytial Virus) | CDC

Factsheet for Older Adults At-Risk for Severe RSV:

Older adults are at high risk for severe RSV disease (

Factsheet for RSV in Infants & Young Children: RSV in Infants and Young Children (

* Note: On October 23, 2023, CDC released a health advisory notice to communicate interim recommendations regarding the limited supply of nirsevimab, the new preventive antibody to protect infants against severe RSV.

Read more: Limited Availability of Nirsevimab in the United States—Interim CDC Recommendations

16 views0 comments
bottom of page